Blood cancers, Myeloma
Results
Phase 1/2
This trial looked at DNA vaccine therapy after a stem cell transplant to help treat people with myeloma.
Recruitment start: 1 March 2004
Recruitment end: 14 December 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Christian Ottensmeier
Bloodwise
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 20 November 2015
CRUK internal database number: 470